Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing
Amount Raised
$78 Million
Round Type
Series B
LausanneBiotechnologyHealth CareTherapeuticsDescription
Silverback Therapeutics™ (“Silverback”) (“the Company”), a private biopharmaceutical company pioneering a new class of immune-modulating ImmunoTAC™ drug conjugates targeting previously inaccessible disease pathways, today announced the close of an oversubscribed $78.5 million Series B financing round. U.S. Venture Partners (“USVP”) led the round, with participation from new investors including Nextech Invest Ltd., Hunt Investment Group, Pontifax Venture Capital, Colt Ventures LP and NS Investment. Existing investors participating in the financing include OrbiMed Advisors LLC, Bristol-Meyers Squibb and Alexandria Venture Investments, LLC
Quick answer
Asceneuron raised $78 Million in a Series B round, dated March 11, 2020. Asceneuron is based in Lausanne, Vaud, Switzerland.
- How much did Asceneuron raise?
- Asceneuron raised $78 Million in a Series B round on March 11, 2020.
- What does Asceneuron do?
- Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need.
- Where is Asceneuron based and how big is it?
- Asceneuron is based in Lausanne, Vaud, Switzerland.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Asceneuron that raised within 45 days of this round, from Fundz verified event records.
- Fate Therapeutics raised $50M on April 21, 2020.
- Phio Pharmaceuticals raised $4.4M on April 14, 2020.
- Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
- Legend Biotech raised $150M on April 7, 2020.
- Vaxcyte, Inc. raised $110M on April 3, 2020.
- Windtree Therapeutics raised an undisclosed amount (Grant) on March 31, 2020.
Who to call at Asceneuron, and when
A new round usually means Asceneuron is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Asceneuron raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Asceneuron, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Asceneuron. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Asceneuron raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAsceneuron raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.